MedPath

This is study to compare efficacy of two beta blockers, propanolol and carvedilol combined with endoscopic therapy for reduction of pressure in veins draining blood from liver to heart and risk of rebleeding in patients with first episode of bleed from dilated esophgeal blood vessels

Not Applicable
Completed
Conditions
Health Condition 1: null- Chronic liver disease patients presenting with first episode of variceal bleeding
Registration Number
CTRI/2013/10/004119
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Chronic liver disease patients presenting with first episode of variceal bleeding and consenting for the study

Exclusion Criteria

1. Failure to give consent to participate in the study

2. Previous medical, surgical or endoscopic treatment for portal hypertension.

3. Child-Pugh score >9

4. Neoplastic disease of any site

5. Splenic or portal vein thrombosis

6. Pregnancy

7. Contraindication to beta-blockers (atrioventricular block, sinus bradycardia with heart rate <50 beats per minute, arterial hypotension with systolic blood pressure <90 mm Hg, heart failure, asthma, peripheral arterial disease, or diabetes needing insulin treatment)

8. Renal failure

9. Bleeding other than esophageal varix

10. Inability to come for follow up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath